US6479487B1 - 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines - Google Patents

6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines Download PDF

Info

Publication number
US6479487B1
US6479487B1 US09/247,053 US24705399A US6479487B1 US 6479487 B1 US6479487 B1 US 6479487B1 US 24705399 A US24705399 A US 24705399A US 6479487 B1 US6479487 B1 US 6479487B1
Authority
US
United States
Prior art keywords
group consisting
amino
integer
cyclopentylpurine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/247,053
Inventor
Jennifer A. Dumont
Alan J. Bitonti
David R. Borcherding
Norton P. Peet
H. Randall Munson, Jr.
Patrick W. Shum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventisub LLC
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13510998P priority Critical
Priority to US3097598A priority
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Priority to US09/247,053 priority patent/US6479487B1/en
Assigned to HOECHST MARION ROUSSEL, INC. reassignment HOECHST MARION ROUSSEL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PEET, NORTON P., BORCHERDING, DAVID R., MUNSON, H. RANDALL, SHUM, PATRICK W-K, BITONTI, ALAN J., DUMONT, JENNIFER A.
Assigned to AVENTIS PHARMACETICALS INC. reassignment AVENTIS PHARMACETICALS INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HOECHST MARION ROUSSEL, INC.
Priority claimed from US10/178,494 external-priority patent/US6642231B2/en
Publication of US6479487B1 publication Critical patent/US6479487B1/en
Application granted granted Critical
Assigned to HMR PHARMA INC. reassignment HMR PHARMA INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AVENTIS PHARMACEUTICALS INC.
Assigned to AVENTIS HOLDINGS INC. reassignment AVENTIS HOLDINGS INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HMR PHARMA INC.
Assigned to AVENTISUB II INC. reassignment AVENTISUB II INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AVENTIS HOLDINGS INC.
Anticipated expiration legal-status Critical
Application status is Expired - Fee Related legal-status Critical

Links